Remimazolam for general anesthesia in a patient with aortic stenosis and severe obesity undergoing transcatheter aortic valve implantation.
Atsushi KainumaAyaka KoyamaMao KinoshitaJun IidaTeiji SawaPublished in: JA clinical reports (2024)
Owing to its pharmacological advantages, remimazolam may be an option for anesthesia induction and maintenance in severely obese patients with unstable circulation.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- weight loss
- aortic valve replacement
- transcatheter aortic valve replacement
- metabolic syndrome
- ejection fraction
- aortic valve
- left ventricular
- type diabetes
- insulin resistance
- adipose tissue
- coronary artery disease
- bariatric surgery
- case report
- early onset
- high fat diet induced
- weight gain
- obese patients
- body mass index